Dendritic cell vaccination as a treatment modality for melanoma

Phase II Trial of Dendritic Cells Loaded with Antigens from Self-Renewing, Proliferating Autologous Tumor Cells as Patient-Specific Antitumor Vaccines in Patients with Metastatic Melanoma: Final Report

(2009) Robert O. Dillman et al.   CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS

Melanoma and Immunotherapy

(2009) Alexander M.M. Eggermont et al.   HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA

Myeloid dendritic cell: From sentinel of immunity to key player of peripheral tolerance?

(2009) Kerstin Steinbrink et al.   HUMAN IMMUNOLOGY

Phase I/II Trial of Tremelimumab in Patients With Metastatic Melanoma

(2009) Luis H. Camacho et al.   JOURNAL OF CLINICAL ONCOLOGY

Phase Ib Trial Assessing Autologous, Tumor-pulsed Dendritic Cells as a Vaccine Administered With or Without IL-2 in Patients With Metastatic Melanoma

(2009) Bruce G. Redman et al.   JOURNAL OF IMMUNOTHERAPY

Autoimmune Antibodies and Recurrence-Free Interval in Melanoma Patients Treated With Adjuvant Interferon

(2009) Marna G. Bouwhuis et al.   JNCI-Journal of the National Cancer Institute

Primary melanomas of the esophagus and anorectum: epidemiologic comparison with melanoma of the skin

(2009) Timothy R. Coté et al.   MELANOMA RESEARCH

Peripheral blood lymphocytes genetically modified to express the self/tumor antigen MAGE-A3 induce antitumor immune responses in cancer patients

(2008) R. Fontana et al.   BLOOD

Topical imiquimod and intralesional interleukin-2 increase activated lymphocytes and restore the Th1/Th2 balance in patients with metastatic melanoma

(2008) D.S. Green et al.   BRITISH JOURNAL OF DERMATOLOGY

Phase I/II Study of Ipilimumab for Patients With Metastatic Melanoma

(2008) Jeffrey S. Weber et al.   JOURNAL OF CLINICAL ONCOLOGY

Recent Trends in Incidence of Cutaneous Melanoma among US Caucasian Young Adults

(2008) Mark P. Purdue et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

Adjuvant therapy of melanoma with interferon: lessons of the past decade

(2008) Paolo A Ascierto et al.   Journal of Translational Medicine

A phase I clinical study of vaccination of melanoma patients with dendritic cells loaded with allogeneic apoptotic/necrotic melanoma cells. Analysis of toxicity and immune response to the vaccine and of IL-10 -1082 promoter genotype as predictor of disease progression

(2008) Erika M von Euw et al.   Journal of Translational Medicine

The tumor microenvironment and its role in promoting tumor growth

(2008) T L Whiteside   ONCOGENE

Comparison of α-Type-1 polarizing and standard dendritic cell cytokine cocktail for maturation of therapeutic monocyte-derived dendritic cell preparations from cancer patients

(2008) Redas Trepiakas et al.   VACCINE